Royal Bank of Canada’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-301,185
Closed -$5.42M 6661
2020
Q2
$5.42M Buy
301,185
+78,803
+35% +$1.42M ﹤0.01% 1665
2020
Q1
$1.59M Buy
222,382
+92,022
+71% +$656K ﹤0.01% 2318
2019
Q4
$3.11M Buy
130,360
+22,096
+20% +$527K ﹤0.01% 2098
2019
Q3
$2.9M Buy
108,264
+18,308
+20% +$491K ﹤0.01% 2067
2019
Q2
$2.44M Sell
89,956
-45
-0% -$1.22K ﹤0.01% 2190
2019
Q1
$3.12M Buy
90,001
+43,670
+94% +$1.52M ﹤0.01% 1993
2018
Q4
$904K Buy
46,331
+36,583
+375% +$714K ﹤0.01% 2721
2018
Q3
$259K Sell
9,748
-2,663
-21% -$70.8K ﹤0.01% 3764
2018
Q2
$469K Buy
12,411
+3,457
+39% +$131K ﹤0.01% 3294
2018
Q1
$292K Sell
8,954
-89,832
-91% -$2.93M ﹤0.01% 3498
2017
Q4
$4.81M Buy
98,786
+87,445
+771% +$4.26M ﹤0.01% 1695
2017
Q3
$612K Buy
11,341
+5,191
+84% +$280K ﹤0.01% 3010
2017
Q2
$346K Sell
6,150
-389
-6% -$21.9K ﹤0.01% 3313
2017
Q1
$256K Buy
6,539
+828
+14% +$32.4K ﹤0.01% 3563
2016
Q4
$128K Sell
5,711
-6,139
-52% -$138K ﹤0.01% 4012
2016
Q3
$269K Buy
11,850
+700
+6% +$15.9K ﹤0.01% 3518
2016
Q2
$263K Sell
11,150
-374
-3% -$8.82K ﹤0.01% 3558
2016
Q1
$234K Sell
11,524
-10,024
-47% -$204K ﹤0.01% 3631
2015
Q4
$1.11M Buy
21,548
+8,626
+67% +$444K ﹤0.01% 2472
2015
Q3
$550K Sell
12,922
-1,152
-8% -$49K ﹤0.01% 2881
2015
Q2
$640K Buy
14,074
+12,550
+823% +$571K ﹤0.01% 2923
2015
Q1
$58K Buy
1,524
+1,250
+456% +$47.6K ﹤0.01% 4452
2014
Q4
$8K Buy
274
+120
+78% +$3.5K ﹤0.01% 5095
2014
Q3
$4K Buy
+154
New +$4K ﹤0.01% 5140
2014
Q1
Sell
-1,000
Closed -$26K 5498
2013
Q4
$26K Sell
1,000
-350
-26% -$9.1K ﹤0.01% 4525
2013
Q3
$36K Buy
+1,350
New +$36K ﹤0.01% 4388